Exclusive

Publication

Byline

Singapore Clinical Trial: A randomized, placebo-controlled, participant- and investigator-blinded study to evaluate the efficacy in reducing atrial fibrillation burden (AFB) as well as the safety, tolerability, and pharmacokinetics of oral PKN605 in participants with atrial fibrillation

Singapore, April 18 -- The Health Sciences Authority received information related to the study titled 'A randomized, placebo-controlled, participant- and investigator-blinded study to evaluate the eff... Read More


Singapore Clinical Trial: A Phase 2/3 Randomized Study to Evaluate the Safety, Efficacy, and Optimal Dose of Telisotuzumab Adizutecan in Combination with Osimertinib as First-Line Treatment in Patients with Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer

Singapore, April 18 -- The Health Sciences Authority received information related to the study titled 'A Phase 2/3 Randomized Study to Evaluate the Safety, Efficacy, and Optimal Dose of Telisotuzumab ... Read More


Singapore Clinical Trial: A Study to Evaluate the Effect of Fasting Duration and Temporary Withholding of Tirzepatide on Retained Gastric Contents Using Gastric Ultrasound in Participants with Type 2 Diabetes Mellitus and Participants with Overweight or Obesity without Type 2 Diabetes Mellitus.

Singapore, April 18 -- The Health Sciences Authority received information related to the study titled 'A Study to Evaluate the Effect of Fasting Duration and Temporary Withholding of Tirzepatide on Re... Read More


Singapore Clinical Trial: A Phase 1/2 Open-Label, Umbrella Platform Design Study of Investigational Agents in Combination With Pembrolizumab (MK-3475) With or Without Chemotherapy in Participants With 1L Locally Advanced Unresectable/Metastatic Esophageal Cancer: KEYMAKER-U06 Substudy 06E

Singapore, April 18 -- The Health Sciences Authority received information related to the study titled 'A Phase 1/2 Open-Label, Umbrella Platform Design Study of Investigational Agents in Combination W... Read More


Fuel to cost more from midnight as govt announces price hike

Dhaka, April 18 -- The government has hiked the prices of four types of fuel, increasing rates by Tk 15 to Tk 20 per litre in a single jump. The Ministry of Power, Energy, and Mineral Resources annou... Read More


War of words escalates: Iran accuses Donald Trump of 'seven false claims'

India, April 18 -- Iranian Parliament Speaker Mohammad Bagher Ghalibaf, who led Tehran's delegation in recent talks with the United States in Islamabad, on Saturday accused US President Donald Trump o... Read More


Meghalaya Jobs 2026 : Apply for Engineer post in MEGCAB

Guwahati, April 18 -- Applications are invited for recruitment of various technical positions or jobs in MEGCAB Meghalaya in 2026. Meghalaya Co-operative Apex Bank Limited (MEGCAB) is inviting applic... Read More


JAMB says kidnapped Benue travellers not UTME candidates

Nigeria, April 18 -- The Joint Admissions and Matriculation Board (JAMB) has said that individuals recently kidnapped in Benue State were not candidates of the 2026 Unified Tertiary Matriculation Exam... Read More


Toyota Yaris Cross refresh adds sharper styling and updated hybrid options

India, April 18 -- Toyota has updated the Yaris Cross compact SUV for Europe with design and feature changes, although the model is not currently offered in India. It remains one of the brand's most i... Read More


Fuel shortage disrupts irrigation, farmers return empty-handed

Dhaka, April 18 -- Alauddin, a farmer identified by a single name, has spent four days trying unsuccessfully to get diesel to irrigate his field. On Saturday, he spent hours standing under the scorch... Read More